References
Falck K, Gröhn P, Sorsa M, Vainio H, Heinonen E, Holsti LR. Mutagenicity in urine of nurses handling cytostatic drugs. Lancet. 1979;8128:1250–1.
Crauste-Manciet S, Sessink PJ, Ferrari S, Jomier JY, Brossard D. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Ann Occup Hyg. 2005;49:619–28.
Rioufol C, Ranchon F, Schwiertz V, et al. Administration of anticancer drugs: exposure in hospital nurses. Clin Ther. 2014;36:401–7.
International Society of Oncology Pharmacy Practicioners Standards Committee. ISOPP standards of practice. Safe handling of cytotoxics. J Oncol Pharm Pract. 2007;13(Suppl.):1–81.
Nygren O, Olofsson E, Johansson L. Spill and leakage using a drug preparation system based on double-filter technology. Ann Occup Hyg. 2008;52:95–8.
Turci R, Sottani C, Spagnoli G, Minoia C. Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods. J Chromatogr B. 2003;789:169–209.
Gaba RC. Hazardous chemical splatter during liver chemoembolisation. J Vasc Interv Radiol. 2010;21:1663–4.
Guillemette A, Langlois H, Voisine M, et al. Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: the centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device. J Oncol Pharm Pract. 2014;20:426–32.
Acknowledgments
The authors thank Doran International for providing free samples of Kemoline 10TM to perform this study and for the reimbursement of accommodation and transport costs relating to the presentation made by Ousseini Sidikou at the 12th European GERPAC Conference (October 2014).
Conflict of interest
None.
Ethical standard
This article does not contain any studies with human participants or animals performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sidikou, O., Simon, N., Sergent, G. et al. In Vitro Assessment of a New Extension Set Intended to Reduce Occupational Exposure to Antineoplastic Drugs During Hepatic Chemoembolisation. Cardiovasc Intervent Radiol 39, 141–143 (2016). https://doi.org/10.1007/s00270-015-1140-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-015-1140-1